| abstract |
The invention provides a novel myogenesis promotor, a novel muscle atrophy inhibitor, a novel composition or a novel TAZ activator. The myogenesis promotor, the muscle atrophy inhibitor, the composition and the TAZ activator include a composition represented by the following Formula (I) as an active ingredient. In Formula (I), R 1 represents a hydrogen atom or an alkyl group; R 2 represents an aryl group, a heterocyclic group, an alkyl group or the like; R 3 represents —NR 5 R 6 or —N═C—R 7 ; each of R 5 and R 6 independently represents a hydrogen atom, an alkyl group or the like; R 7 represents —NR 10 R 11 , an aryl group or a heterocyclic group; R 8 represents a hydrogen atom, an alkyl group or the like; R 9 represents a hydrogen atom, an alkyl group or the like; each of R 10 and R 11 independently represents a hydrogen atom, an alkyl group or the like; R 4 represents a cyano group or —C(═O)R 12 ; and R 12 represents an aryl group, a heterocyclic group, an alkyl group or the like. |